Advertisement
Home Tags Prescription Drugs

Tag: Prescription Drugs

For patients with chronic obstructive pulmonary disease

Once-Daily Triple-Tx Improves Lung Function, HRQoL in COPD

Significantly improved FEV1 and St. George's Respiratory Questionnaire scores
Studies often fail to include information on outcomes by medication adherence in type 2 diabetes

Studies Often Fail to Include Info on T2DM Medication Adherence

Relative risks of good versus poor adherence to meds reduced for all-cause mortality, hospitalization
There is no significant difference in cognitive function for patients treated with evolocumab or placebo added to statin therapy

Evolocumab Doesn’t Affect Cognition When Added to Statins

No significant between-group difference for patients receiving evolocumab or placebo added to statins
There does not appear to be significant racial differences in preoperative or intraoperative medication administration for children undergoing emergency appendectomies

Few Racial Differences in Peds Anesthesia Meds Administration

Findings after adjustment for age, gender, attending anesthesiologist practice patterns
Subcutaneous exendin appears to be safe and effective in treating post-bariatric hypoglycemia

Subcutaneous Exendin Treats Post-Bariatric Hypoglycemia

Injections well tolerated with no adverse effects reported
Increases in the price of nitroprusside and isoproterenol correlated with reductions in their use

Nitroprusside, Isoproterenol Prescribing Drops With Price Rise

Decrease in absolute number of patients treated from 2012 to 2015 with major increase in price
For patients with super-refractory status epilepticus

Brexanolone Tolerated in Super-Refractory Status Epilepticus

Associated with high rate of third-line agent weaning; no serious adverse events attributed to the drug
Several significant interactions can occur between cannabidiol and antiepileptic drugs

Interactions Occur With Cannabidiol, Antiepileptic Drugs

Most observed mean level changes fall within accepted therapeutic range
For men with nonmetastatic prostate cancer who are receiving androgen deprivation therapy

Osteoporosis Meds Up BMD in Nonmetastatic Prostate Cancer

Review shows improved bone mineral density in men receiving androgen deprivation therapy

mAb Glucagon Receptor Blocker Suitable for Further Development

REGN1193 inhibited glucose increase stimulated by glucagon in dose-dependent manner